Cerebrovascular Disease: Quality of Life (CODE: QoL)

Launched by UNIVERSITY OF ZURICH · May 29, 2024

Keywords

ClinConnect Summary

The CODE: QoL study is looking to understand how strokes and other cerebrovascular conditions affect the quality of life for both patients and their caregivers. Researchers want to explore the levels of stress experienced by these individuals and what factors might contribute to their overall well-being. Patients who have had a stroke, as well as their caregivers, will be asked to fill out questionnaires and provide a hair sample to measure stress hormones. There will also be a comparison group of individuals who have not experienced a stroke, which will help researchers understand how these conditions impact quality of life.

To participate, patients must be over 18 years old and have recently experienced a stroke or a related condition, while caregivers must also be 18 or older. Both the patients and their caregivers need to be able to give their consent to join the study. Participants will be involved in answering questions and providing samples, helping to shed light on the challenges faced by those living with the effects of a stroke. This study is currently recruiting participants at the University Hospital of Zurich and aims to provide valuable insights into the well-being of patients and their caregivers.

Gender

ALL

Eligibility criteria

• Control group:
• Inclusion criteria:
• • over 18 years old
• • No previous stroke OR previous stroke \>3 years ago
• • No significant disability (maximum mRS 1)
• • ambulatory patients at the University Hospital of Zurich (USZ), Dept. of Neurology
• • Patients' AND caregiver's ability to give informed consent
• • Patients' AND close relative's / caregiver's willingness to participate
• Exclusion criteria:
• • • Medication with steroid hormones (prednisone, prednisolone, dexamethasone, methylprednisolone, hydrocortisone etc.) within last 3 months
• Main Group:
• Inclusion criteria:
• • over 18 years old
• • Patients diagnosed with either transient ischemic attack, ischemic stroke or intracerebral hemorrhage and their caregivers
• • Caregiver of a patient as described above, age over 18 years
• • Hospitalized or ambulatory patients at the University Hospital of Zurich (USZ) included within 28 days from event.
• • Patients' AND caregiver's ability to give informed consent
• • Patients' AND caregiver's willingness to participate
• Exclusion criteria:
• • • Medication with steroid hormones (prednisone, prednisolone, dexamethasone, methylprednisolone, hydrocortisone etc.) within last 3 months